Previous studies have shown that meldonium can reduce blood glucose levels in both rodent models of diabetes (STZ injection) and insulin‐resistant models of diabetes (Zucker obese rats), as well as in humans with type 2 diabetes.32, 33, 34. Here, INS is linked to type 2 diabetes mellitus.